Recent & Archived News
September 16, 2019
Bayer Names Daniella Foster New Head of Public Affairs and Sustainability for Consumer Health Division
Bayer today announced Daniella Foster as the new Head of Public Affairs and Sustainability for the Consumer Health Division, effective September 16. In her new role, Daniella will be responsible...
September 12, 2019
Actress Lucy Hale and Bayer Launch #WhyIUD Campaign to Educate Women About IUDs
Actress Lucy Hale is partnering with Bayer, a longstanding leader in women's healthcare, to launch #WhyIUD to help more women get the facts about intrauterine devices (IUDs) so they can make...
September 11, 2019
Bayer introduces next generation CT technology, the MEDRAD® Stellant FLEX CT Injection System
Bayer announced today the introduction of the MEDRAD® Stellant FLEX Computed Tomography (CT) Injection System. Stellant FLEX offers the latest CT injection technology from Bayer with a...
September 10, 2019
Bayer Consumer Health Products Among OTCs Most Recommended by Pharmacists: Survey
Each year, U.S. News & World Report collaborates with Pharmacy Times to ask thousands of pharmacists: which over-the-counter (OTC) products do you recommend the most? The list of top...
September 04, 2019
Bayer Awards $500,000 Grant To The St. Louis Magic House For New STEM Interactive Children's Exhibit
Bayer has awarded The Magic House® St. Louis Children's Museum a $500,000 grant to create the Bayer STEM Pathway, a hands-on, interactive exhibit that will be designed to spark a life-long...
September 03, 2019
Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee
Bayer today announced Marianne De Backer PhD as the new Head of Business Development & Licensing of its Pharmaceuticals Division. She will report to Stefan Oelrich, Member of the Board of...
August 27, 2019
Bayer Invests in Future of Agriculture Through Multi-Year Commitment to 4-H and FFA
As thousands of farmers gather at the annual Farm Progress Show, Bayer announced a multi-year, multi-million-dollar commitment to 4-H and the National FFA Organization to develop future leaders in...
August 13, 2019
JIVI® (antihemophilic factor [recombinant] PEGylated-aucl) Pharmacokinetic Profile Compared to Eloctate® Showed Improved Characteristics in PK Study of Extended Half-life Recombinant FVIII Therapies
A head-to-head study directly comparing the pharmacokinetic (PK) profiles of two extended half-life (EHL) recombinant factor VIII (FVIII) therapies demonstrated improved PK characteristics for...
August 08, 2019
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...
August 06, 2019
Bayer Awards $1.5 Million Grant To BioSTL To Support Organization's Headquarters And Program Expansion In St. Louis' Emerging Technology District
Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region's growing bioscience, innovation and technology community, a $1.5 million grant to support its new...
Want even more Bayer news?
Last Updated: December 14, 2018